Patents by Inventor Annika Jenmalm Jensen

Annika Jenmalm Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino substituted pyrazines as inhibitors or protein kinases
    Patent number: 8436171
    Abstract: The present invention relates to compounds of the general formula (I) wherein R1, R2 and R3 are as defined herein, which can act as inhibitors of protein kinases, specially the Fms-like tyrosine kinase 3 (FLT3). A species illustrative of members of the general formula is The invention also relates to the use of the compounds in therapy, pharmaceutical compositions comprising the compounds and the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of hematological malignancies, such as AML, MLL, T-ALL, B-ALL and CMML, myeloproliferative disorders, other proliferative disorders like cancer, autoimmune disorders and skin disorders like psoriasis and atopic dermatitis.
    Type: Grant
    Filed: January 28, 2009
    Date of Patent: May 7, 2013
    Assignee: Akinion Pharmaceuticals AB
    Inventors: Annika Jenmalm Jensen, Fredrik Lehmann, Erik Nordling, Vendela Parrow
  • Compounds
    Patent number: 7943639
    Abstract: The present invention relates to compounds of the general formula (I), wherein P is sulfone or sulfonamide; and A, B, W, X, Y and R3 are as defined in the description; to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: May 17, 2011
    Assignee: Proximagen Limited
    Inventors: Gary Johansson, Annika Jenmalm-Jensen, Katarina Beierlein
  • NOVEL COMPOUNDS, USE AND PREPARATION THEREOF
    Publication number: 20110098310
    Abstract: The present invention relates to compounds of the general formula (I) wherein R1, R2 and R3 are as defined herein, which can act as inhibitors of protein kinases, specially the Fms-like tyrosine kinase 3 (FLT3). The invention also relates to the use of the compounds in therapy, pharmaceutical compositions comprising the compounds and the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of hematological malignancies, such as AML, MLL, T-ALL, B-ALL and CMML, myeloproliferative disorders, other proliferative disorders like cancer, autoimmune disorders and skin disorders like psoriasis and atopic dermatitis.
    Type: Application
    Filed: January 28, 2009
    Publication date: April 28, 2011
    Inventors: Annika Jenmalm Jensen, Fredrik Lehmann, Bjorn M. Nilsson, Erik Nordling, Vendela Parrow
  • New Compounds
    Publication number: 20100222330
    Abstract: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: May 17, 2010
    Publication date: September 2, 2010
    Applicant: BIOVITRUM AB
    Inventors: Patrizia Caldirola, Gary Johansson, Andrew Mott, Katarina Beierlein, Markus Thor, Lars Tedenborg, Ulf Bremberg, Annika Jenmalm Jensen
  • Substituted naphthalene sulfonamides
    Patent number: 7572787
    Abstract: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: August 11, 2009
    Assignee: Biovitrum AB
    Inventors: Patrizia Caldirola, Ulf Bremberg, Gary Johansson, Andrew Mott, Annika Jenmalm Jensen, Katarina Beierlien, Markus Thor, Lars Tedenborg
  • Bicyclic sulfonamide compounds
    Patent number: 7144883
    Abstract: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: December 5, 2006
    Assignee: Biovitrum AB
    Inventors: Patrizia Caldirola, Gary Johansson, Andrew Mott, Katarina Beierlien, Markus Thor, Lars Tedenborg, Ulf Bremberg, Annika Jenmalm Jensen
  • New compounds
    Publication number: 20040024210
    Abstract: The present invention relates to compounds of the general formula (I), 1
    Type: Application
    Filed: June 19, 2003
    Publication date: February 5, 2004
    Inventors: Gary Johansson, Annika Jenmalm-Jensen, Katarina Beierlein
  • New compounds
    Publication number: 20030158202
    Abstract: The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: June 11, 2002
    Publication date: August 21, 2003
    Inventors: Patrizia Caldirola, Gary Johansson, Andrew Mott, Katarina Beierlien, Markus Thor, Lars Tedenborg, Ulf Bremberg, Annika Jenmalm Jensen